Nano-X Imaging Ltd.
General ticker "NNOX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $227.8M (TTM average)
Nano-X Imaging Ltd. does not follow the US Stock Market performance with the rate: -29.1%.
Estimated limits based on current volatility of 3.3%: low 0.78$, high 0.83$
Factors to consider:
- Earnings expected soon, date: 2026-09-09 bmo
- Total employees count: 40 as of 2020
- Current price 59.9% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.91$, 4.85$]
- 2026-12-31 to 2027-12-31 estimated range: [1.88$, 4.69$]
Financial Metrics affecting the NNOX estimates:
- Positive: with PPE of -2.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -21.67 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 15.60 > -0.64
Short-term NNOX quotes
Long-term NNOX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9.90MM | $11.28MM | $13.02MM |
| Operating Expenses | $72.49MM | $68.03MM | $73.72MM |
| Operating Income | $-62.59MM | $-56.75MM | $-60.70MM |
| Non-Operating Income | $1.47MM | $2.87MM | $-16.11MM |
| R&D Expense | $26.05MM | $20.18MM | $19.24MM |
| Income(Loss) | $-61.12MM | $-53.87MM | $-76.81MM |
| Taxes | $-0.34MM | $-0.36MM | $-1.79MM |
| Net Income(Loss)* | $-60.78MM | $-53.52MM | $-75.02MM |
| Stockholders Equity | $195.51MM | $189.12MM | $139.73MM |
| Inventory | $2.36MM | $1.49MM | $3.07MM |
| Assets | $218.65MM | $210.00MM | $162.16MM |
| Operating Cash Flow | $-44.78MM | $-36.60MM | $-40.79MM |
| Capital expenditure | $3.30MM | $2.77MM | $4.21MM |
| Investing Cash Flow | $35.43MM | $-20.05MM | $29.37MM |
| Financing Cash Flow | $27.25MM | $39.50MM | $21.37MM |
| Earnings Per Share** | $-1.08 | $-0.91 | $-1.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.